Associations between CYP2C19 (∗2, rs4244285) and increased hospital stays in kidney transplant patients treated with tacrolimus have been reported (evidence level 3) (Bosó et al., 2013), although this finding has not been confirmed. Here, CYP2C19 is linked to kidney transplant.